Saturday, October 31, 2026

Clean Energy Fuels Stock Plummets 15% As It Underperforms The Market

ViaNews Editorial Team

December 13, 2023

Clean Energy Fuels Stock Plummets 15% As It Underperforms The Market

(VIANEWS) - Clean Energy Fuels Shares Plummet 15.2% in Bullish Trading Session Clean Energy Fuels' (NASDAQ: CLNE) share price dropped 15.2% during Tuesday's trading session to close at EUR3.07 after three consecutive days of gains, even as the NASDAQ index gained 0.08% to EUR14,443.93. Despite an overall bullish trend observed today's trading session, Clean Energy Fuels saw their price decline dramatically despite generally bullish market conditions. Clean Energy Fuels' closing price on Friday was EUR3.62, representing a decline of 41.71% since its 52-week high of EUR6.21. This recent setback has caused investors to become worried, so its future performance will be carefully assessed to ascertain if Clean Energy Fuels can recover.

About Clean Energy Fuels

Clean Energy Fuels Corp. specializes in offering natural gas as a sustainable alternative fuel option for vehicle fleets in North America, as well as associated fueling solutions. The company provides renewable natural gas (RNG), compressed natural gas (CNG), and liquefied natural gas (LNG) fuel for medium and heavy-duty vehicles as well as operation and maintenance services for fleet customer stations. Clean Energy Fuels Corp. also designs, builds, operates and maintains vehicle fueling stations; sells and services compressors; transports CNG, RNG and LNG through virtual natural gas pipelines and interconnects; as well as selling these gases at market. The company provides U.S. federal, state and local government credits as well as credits, grants, and incentives. Clean Energy Fuels Corp. specializes in dairy and livestock waste RNG projects for various industries such as heavy-duty trucking, airports, refuse collection services, public transit systems, industrial energy users and government fleets. As of December 31st 2022, approximately 1,000 fleet customers operating approximately 50,000 vehicles were serviced. Their headquarters can be found in Newport Beach California.

Yearly Analysis

Clean Energy Fuels' stock is currently undervalued relative to its 52-week high, yet above its 52-week low. Sales growth this year is projected at 2.4% while next year it could increase further to 4.1%. EBITDA at Clean Energy Fuels stands at 1.93 and indicates the company is making profits through operations. Given this information, investors may wish to explore Clean Energy Fuels as an investment opportunity if they believe its sales growth will accelerate in coming years. But investors must also take into account other considerations, including financial statements from Clean Energy Fuels as well as industry trends and overall market conditions when making any decisions regarding potential investments in this company.

Technical Analysis

Clean Energy Fuels' stock prices are trading significantly below both their 50-day and 200-day moving averages, signalling an ongoing downward trend over both short and long terms. Furthermore, its reported volume of 3655840 was 100% above its average volume of 1821970 suggesting significant trading activity. Clean Energy Fuels' volatility over the last quarter was relatively low, with an average intraday fluctuation of just 2.91% on average; its highest amplitude of average volatility being just 2.919% during that time - signifying that price movements had been relatively steady. According to the stochastic oscillator, Clean Energy Fuels' stock is currently oversold (=20), suggesting it may be undervalued and due for an upward price rebound. Clean Energy Fuels's current stock prices and indicators may suggest it may be an opportune time for investors to purchase its stock, provided they believe in its long-term prospects and growth potential. Before making any decisions regarding investments or purchases from Clean Energy Fuels it is wise to conduct in-depth research and analysis prior to making any definitive moves.

Quarter Analysis

Clean Energy Fuels' sales growth appears to be negative both this quarter and next quarter. This could indicate that Clean Energy Fuels is having difficulty expanding their sales growth - an indicator of financial health for any company. Year-on-year quarterly revenue growth has also declined by 24%, signalling to investors that revenue may no longer be increasing as rapidly. This may cause concern as it suggests the business model of the company may no longer be successful enough. Keep in mind, however, that these figures rely on limited data and should be evaluated along with other factors, including overall financial performance, competitive landscape and industry trends. Before making any investment decisions based on such estimates alone. it is wise for investors to conduct more due diligence prior to committing.

Equity Analysis

Investment Outlook for Clean Energy Fuels (ticker symbol: CLNE). Clean Energy Fuels, which offers natural gas as transportation fuel in both North America and Europe, reported an EPS figure of EUR-0.41, suggesting they are currently incurring losses that are not profitable for investors in the short term. Also, the company's return on equity (ROE) for the past twelve months stands at negative -13.21% - this shows that their profits do not match up to justify the amount of shareholder equity invested into their business and can be cause for alarm among potential investors. Given these financial metrics, investors should use caution before investing in Clean Energy Fuels. Wait until there is evidence of positive EPS and ROE before considering investing.

More news about Clean Energy Fuels (CLNE).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com